MicroRNA profile in site-specific head and neck squamous cell cancer

Anticancer Research

Volumn 35, Issue 4, 2015, Pages 2455-2463

  Kalfert, David ^a   Pesta, Martin ^b,c   Kulda, Vlastimil ^b   Topolcan, Ondrej ^c   Ryska, Ales ^a   Celakovsky, Petr ^a   Laco, Jan ^a   Ludvikova, Marie ^b  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Head and neck squamous cell carcinoma; Hypopharyngeal cancer; Laryngeal; let 7a; MicroRNA; miR 200c; miR 21; miR 34a; miR 375; Oropharyngeal

Indexed keywords

MICRORNA; MICRORNA 200C; MICRORNA 21; MICRORNA 34A; MICRORNA 375; MICRORNA LET 7A; UNCLASSIFIED DRUG; MIRN34 MICRORNA, HUMAN; TRANSCRIPTOME; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; AGED; BIOSYNTHESIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; LARYNX TUMOR; MIDDLE AGED; OROPHARYNX TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84928382269     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr.
2. Carthew RW and Sontheimer EJ: Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642-655, 2009.
3. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
4. Ludvikova M, Pesta M, Holubec L, Jr. and Kalfert D: New aspects of tumor pathobiology. Cesk Patol 45: 94-99, 2009.
5. Liu X, Chen Z, Yu J, Xia J and Zhou X: MicroRNA profiling and head and neck cancer. Comp Funct Genomics: 837514, 2009.
6. Lujambio A and Esteller M: CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle 6: 1455-1459, 2007.
7. Suzuki H, Maruyama R, Yamamoto E and Kai M: Epigenetic alteration and microRNA dysregulation in cancer. Front Genet 4: 258, 2013.
8. Metias SM, Lianidou E and Yousef GM: MicroRNAs in clinical oncology: at the crossroads between promises and problems. J Clin Pathol 62: 771-776, 2009.
9. Hagan JP and Croce CM: MicroRNAs in carcinogenesis. Cytogenet Genome Res 118: 252-259, 2007.
10. Fabbri M, Ivan M, Cimmino A, Negrini M and Calin GA: Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther 7: 1009-1019, 2007.
11. Kumar B, Yadav A, Lang J, Teknos TN and Kumar P: Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS One 7: e37601, 2012.
12. Roush S and Slack FJ: The let-7 family of microRNAs. Trends Cell Biol 18: 505-516, 2008.
13. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack FJ: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005.
14. Yu CC, Chen YW, Chiou GY, Tsai LL, Huang PI, Chang CY, Tseng LM, Chiou SH, Yen SH, Chou MY, Chu PY and Lo WL: MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol 47: 202-210, 2011.
15. Krichevsky AM and Gabriely G: miR-21: a small multi-faceted RNA. J Cell Mol Med 13: 39-53, 2009.
16. Fu X, Han Y, Wu Y, Zhu X, Lu X, Mao F, Wang X, He X and Zhao Y: Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur J Clin Invest 41: 1245-1253, 2011.
17. Ren J, Zhu D, Liu M, Sun Y and Tian L: Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. Eur J Cancer 46: 3409-3416, 2010.
18. Kulda V, Pesta M, Topolcan O, Liska V, Treska V, Sutnar A, Rupert K, Ludvikova M, Babuska V, Holubec L, Jr. and Cerny R: Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet 200: 154-160, 2010.
19. Pan X, Wang ZX and Wang R: MicroRNA-21: a novel thera peutic target in human cancer. Cancer Biol Ther 10: 1224-1232, 2010.
20. Liu J, Zhu H, Yang X, Ge Y, Zhang C, Qin Q, Lu J, Zhan L, Cheng H and Sun X: MicroRNA-21 is a novel promising target in cancer radiation therapy. Tumour Biol 35: 3975-3979, 2014.
21. Chen J and Wang X: MicroRNA-21 in breast cancer: diagnostic and prognostic potential. Clin Transl Oncol 16: 225-233, 2014.
22. Mongroo PS and Rustgi AK: The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther 10: 219-222, 2010.
23. Lo WL, Yu CC, Chiou GY, Chen YW, Huang PI, Chien CS, Tseng LM, Chu PY, Lu KH, Chang KW, Kao SY and Chiou SH: MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol 223: 482-495, 2011.
24. Agostini M and Knight RA: miR-34: from bench to bedside. Oncotarget 5: 872-881, 2014.
25. Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, Klausen M, Pilpel Y, Nielsen FC, Oren M and Lund AH: p53- independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 17: 236-245, 2010.
26. Chen F and Hu SJ: Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. J Biochem Mol Toxicol 26: 79-86, 2012.
27. Li XJ, Ren ZJ and Tang JH: MicroRNA-34a: a potential therapeutic target in human cancer. Cell Death Dis 5: e1327, 2014.
28. Kinoshita T, Hanazawa T, Nohata N, Okamoto Y and Seki N: The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways. J Hum Genet 57: 556-563, 2012.
29. Yan JW, Lin JS and He XX: The emerging role of miR-375 in cancer. Int J Cancer 135: 1011-1018, 2014.
30. Sobin LH, Gospodarowicz MK and Wittekind C: TNM Classification of Malignant Tumours, 7th Edition: Wiley-Blackwell, 2009.
31. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
32. Ramqvist T and Dalianis T: An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and prevention. Anticancer Res 31: 1515-1519, 2011.
33. Silva SD, Nonogaki S, Soares FA and Kowalski LP: p16 (INK4a) has clinicopathological and prognostic impact on oropharynx and larynx squamous cell carcinoma. Braz J Med Biol Res 45: 1327-1333, 2012.
34. Gourin CG, Conger BT, Porubsky ES, Sheils WC, Bilodeau PA and Coleman TA: The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma. Laryngoscope 118: 1191-1194, 2008.
35. Chen LH, Tsai KL, Chen YW, Yu CC, Chang KW, Chiou SH, Ku HH, Chu PY, Tseng LM, Huang PI and Lo WL: MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma. J Oncol 2010: 135632, 2010.
36. Heneghan HM, Miller N and Kerin MJ: MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol 10: 543-550, 2010.
37. Pesta M, Klecka J, Kulda V, Topolcan O, Hora M, Eret V, Ludvikova M, Babjuk M, Novak K, Stolz J and Holubec L: Importance of miR-20a expression in prostate cancer tissue. Anticancer Res 30: 3579-3583, 2010.
38. Barber BR, Biron VL, Klimowicz AC, Puttagunta L, Cote DW and Seikaly H: Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma. J Otolaryngol Head Neck Surg 42: 53, 2013.
39. Janiszewska J, Szaumkessel M and Szyfter K: microRNAs are important players in head and neck carcinoma: a review. Crit Rev Oncol Hematol 88: 716-728, 2013.
40. Avissar M, Christensen BC, Kelsey KT and Marsit CJ: MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15: 2850-2855, 2009.
41. Wiklund ED, Gao S, Hulf T, Sibbritt T, Nair S, Costea DE, Villadsen SB, Bakholdt V, Bramsen JB, Sorensen JA, Krogdahl A, Clark SJ and Kjems J: MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS One 6: e27840, 2011.
42. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C, Shan S, Westra W, Sidransky D and Califano JA: MicroRNA altera tions in head and neck squamous cell carcinoma. Int J Cancer 123: 2791-2797, 2008.
43. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, Gullane P, Cummings B and Liu FF: Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 1129-1139, 2010.
44. Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV, Prystowsky MB, Belbin TJ and Schlecht NF: Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 174: 736-745, 2009.
45. Momi N, Kaur S, Rachagani S, Ganti AK and Batra SK: Smoking and microRNA dysregulation: a cancerous combination. Trends Mol Med 20: 36-47, 2014.
46. Avissar M, McClean MD, Kelsey KT and Marsit CJ: MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 30: 2059-2063, 2009.
47. Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, Garnaes E, Rossing M, Specht L, Therkildsen MH, Nauntofte B, Dabelsteen S and von Buchwald C: Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer 104: 830-840, 2011.
48. Lajer CB and von Buchwald C: The role of human papilloma- virus in head and neck cancer. Apmis 118: 510-519, 2010.
49. Romagosa C, Simonetti S, Lopez-Vicente L, Mazo A, Lleonart ME, Castellvi J and Ramon y Cajal S: p16(Ink4a) over expres sion in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene 30: 2087-2097, 2011.
50. Leemans CR, Braakhuis BJ and Brakenhoff RH: The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22, 2011.
51. Overhoff MG, Garbe JC, Koh J, Stampfer MR, Beach DH and Bishop CL: Cellular senescence mediated by p16INK4A-coupled miRNA pathways. Nucleic Acids Res 42: 1606-1618, 2014.
52. Shen Z, Zhan G, Ye D, Ren Y, Cheng L, Wu Z and Guo J: MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Med Oncol 29: 2473-2480, 2012.
53. Ribeiro J and Sousa H: MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a. Mol Biol Rep 41: 1525-1531, 2014.
54. Ogawa T, Saiki Y, Shiga K, Chen N, Fukushige S, Sunamura M, Nagase H, Hashimoto S, Matsuura K, Saijo S, Kobayashi T and Horii A: miR-34a is downregulated in cis-diammi nedic- hloroplatinum treated sinonasal squamous cell carci noma patients with poor prognosis. Cancer Sci 103: 1737-1743, 2012.
55. John K, Wu J, Lee BW and Farah CS: MicroRNAs in head and neck cancer. Int J Dent 2013: 650218, 2013.
56. Peiro-Chova L, Pena-Chilet M, Lopez-Guerrero JA, Garcia-Gimenez JL, Alonso-Yuste E, Burgues O, Lluch A, Ferrer-Lozano J and Ribas G: High stability of microRNAs in tissue samples of compromised quality. Virchows Arch 463: 765-774, 2013.